The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant nab-paclitaxel plus S-1 versus capecitabine plus oxaliplatin for patients with stage III gastric adenocarcinoma after D2 dissection: A multicenter, open-label, randomized phase 3 study.
 
Yu Pengfei
No Relationships to Disclose
 
Yian Du
No Relationships to Disclose
 
Zhiyuan Xu
No Relationships to Disclose
 
Litao Yang
No Relationships to Disclose
 
Jieer Ying
No Relationships to Disclose
 
Ping Chen
No Relationships to Disclose
 
Yunhai Wei
No Relationships to Disclose
 
Yingjie Wu
No Relationships to Disclose
 
Xiaojing Zhang
No Relationships to Disclose
 
Zhilong Yan
No Relationships to Disclose
 
Zhiheng Chen
No Relationships to Disclose
 
Hongtao Xu
No Relationships to Disclose
 
Yong Li
No Relationships to Disclose
 
Zhichao Zheng
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Xiangdong Cheng
No Relationships to Disclose